Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

MBIO

MindBio Therapeutics (MBIO)

MindBio Therapeutics Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:CSE:MBIO
DataHoraFonteTítuloCódigoCompanhia
24/08/202310:00InvestorsHub NewsWireMindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With DepressionCSE:MBIOMindBio Therapeutics Corp
14/06/202309:00InvestorsHub NewsWireMindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of SleepCSE:MBIOMindBio Therapeutics Corp
30/05/202309:00InvestorsHub NewsWireMindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at ScaleCSE:MBIOMindBio Therapeutics Corp
23/05/202309:15InvestorsHub NewsWireMindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive DisorderCSE:MBIOMindBio Therapeutics Corp
11/05/202309:29InvestorsHub NewsWireMindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional DistressCSE:MBIOMindBio Therapeutics Corp
09/05/202310:13InvestorsHub NewsWireMindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy ParticipantsCSE:MBIOMindBio Therapeutics Corp
 Apresentando as notícias mais relevantes sobre:CSE:MBIO